Matsuoka T, Sugiyama A, Miyawaki Y, Hidaka Y, Okuno Y, Sakai H, et al. Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide. Cancer Sci. 2023;: pubmed publisher

Wang H, Lapek J, Fujimura K, Strnadel J, Liu B, Gonzalez D, et al. Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription. Cell Discov. 2018;4:26 pubmed publisher

Wood L, Cox N, Phelps C, Lai S, Poddar A, Talbot C, et al. Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome. Sci Rep. 2016;6:19857 pubmed publisher

Chen T, Margariti A, Kelaini S, Cochrane A, Guha S, Hu Y, et al. MicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF Signaling. Stem Cells. 2015;33:1405-18 pubmed publisher

Kumar B, Rajput S, Dey K, Parekh A, Das S, Mazumdar A, et al. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer. 2013;13:273 pubmed publisher

Mammoto A, Connor K, Mammoto T, Yung C, Huh D, Aderman C, et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009;457:1103-8 pubmed publisher